Clinical Trials Directory

Trials / Completed

CompletedNCT00364702

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Shaare Zedek Medical Center · Academic / Other
Sex
All
Age
10 Years – 20 Years
Healthy volunteers
Accepted

Summary

Using a virtual reality program in screening and treatment of ADHD.

Detailed description

Virtual Reality is a novel program designed to imitate a real classroom environment including various distractions. It includes a head monitor to track eye movements Children aged 10-20 years with ADHD will use the program with and without methylphenidate(1 mg/kg). Their results will be compared to a control group. Parental consent will be obtained.

Conditions

Interventions

TypeNameDescription
DRUGmethylphenidate

Timeline

Start date
2006-08-01
Primary completion
2007-07-01
Completion
2007-07-01
First posted
2006-08-16
Last updated
2011-08-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00364702. Inclusion in this directory is not an endorsement.

Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder (NCT00364702) · Clinical Trials Directory